Search Results for keywords:"personal data"

The National Institutes of Health has announced a closed meeting of the National Institute of General Medical Sciences Special Emphasis Panel from April 25-28, 2025. The meeting will be virtual and aims to review and evaluate Small Business Innovation Research (SBIR) grant applications. This meeting is closed to the public because it will involve discussions that might reveal confidential trade secrets, commercial information, or personal data that could infringe on privacy. Contact persons for the meeting include Lee Warren Slice, Ph.D., and Latarsha J. Carithers, Ph.D.

The National Institute of Diabetes and Digestive and Kidney Diseases announced several upcoming closed meetings to review grant applications. These meetings, scheduled between April 1 and April 25, 2025, will be held virtually and are not open to the public to protect confidential information and personal privacy. The potential discussions may involve sensitive trade secrets, patentable material, or personal data. Contacts for the meetings include Cheryl Nordstrom, Ann Jerkins, and Michele Barnard, who can be reached via the emails provided in the notice.

The National Institutes of Health's National Center for Advancing Translational Sciences has announced two upcoming meetings that will be closed to the public. These meetings are set to take place on April 8-9, 2025, and April 10-11, 2025, and will be held virtually. They will focus on reviewing and evaluating grant applications, discussing sensitive information that includes potential trade secrets and private personal data. The meetings' closed nature is to ensure privacy and confidentiality in dealing with proprietary and personal information.

The National Institute on Aging announced a closed meeting to review and evaluate grant applications for the Alzheimer's Disease Drug Development Program. This meeting is scheduled for January 23, 2025, from 12:00 p.m. to 4:00 p.m. and will be held virtually. The meeting will be closed to the public to protect sensitive information, such as trade secrets and personal data related to the grant applications.

The National Institute on Drug Abuse is holding a closed meeting to review and evaluate grant applications related to preventing the use of electronic nicotine delivery systems (ENDS) among adolescents. This meeting will take place on March 10, 2021, from 9:00 a.m. to 6:00 p.m., and will be held virtually at the National Institutes of Health. The sessions will be closed to the public due to the sensitivity of the content, which includes confidential information and personal data. Yvonne Owens Ferguson, Ph.D., is the contact person for more information.

The Centers for Disease Control and Prevention (CDC) and the Health and Human Services Department announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel scheduled for April 13-14, 2021. The meeting, which will be held via teleconference, aims to review and evaluate grant applications related to public health research in countries like Bangladesh, Thailand, Kenya, and others. The sessions are closed to the public to protect sensitive information, such as trade secrets and personal data about individuals involved in the grant applications. For more details, contact Dr. Hylan Shoob at the CDC.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development has announced a closed meeting scheduled for March 17-18, 2025. The meeting will be held virtually and is not open to the public to protect confidential information related to grant applications, such as trade secrets and personal data. The purpose of the meeting is to review and evaluate these grant applications. Any inquiries about the meeting can be directed to Dr. Helen Huang at the Institute.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases announced a series of upcoming meetings that will be closed to the public. These meetings are scheduled between February 19 and March 16, 2021, and are intended to review and evaluate grant applications related to arthritis, musculoskeletal, and skin diseases. The meetings will be conducted virtually from NIH headquarters in Bethesda, MD, and involve discussions of sensitive information, such as trade secrets and personal data associated with the grant applications. The notice ensures that the confidentiality of the information discussed is maintained.

The National Institute on Aging is holding a meeting focused on evaluating grant applications for a clinical trial involving older individuals. This meeting, scheduled for February 26, 2021, from 11:00 a.m. to 5:00 p.m., will be closed to the public due to the potential disclosure of confidential information such as trade secrets and personal data. The meeting will take place via video at the Gateway Building in Bethesda, Maryland, and will be led by Dr. Maurizio Grimaldi, a Scientific Review Officer.

The National Institutes of Health (NIH) has announced several meetings that will be closed to the public to review grant applications. These meetings will discuss potentially sensitive information, including trade secrets and personal data, which is why they are not open to the public. The meetings will be held virtually from April 1-4, 2025, and involve different committees focused on neuroscience and therapeutic advancements. For more details, contact information is provided for NIH scientific review officers overseeing the proceedings.